VisionSys AI (ADR) (VSA)
Develops BCI technical services and non-invasive EEG applications.
Something off on this page? Send us feedback.
Generates limited revenue from customized BCI technical services based on a system that uses AI-enabled software and hardware to decode brainwave and other signals. Near-term commercialization centers on non-invasive EEG and general-wellness applications, while medical and overseas applications depend on validation, approvals, market acceptance and capital.
Operates an early-stage brain-computer-interface technology and services business through Beijing Wangwen Zhisuan Technology in mainland China. Its acquired System combines brainwave, facial-expression and head-movement signals with AI-enabled algorithms for signal processing and decoding, software-hardware coordination, analysis and external-device control.
Generates limited revenue from customized technical services covering signal decoding, development, testing, optimization, implementation, device adaptation, software-hardware integration, consulting, maintenance and support. Near-term work centers on non-invasive EEG, sleep support, attention monitoring, meditation, general wellness and rehabilitation support; supplier-sourced devices may complement the service model. Medical and overseas applications depend on validation, approvals, market acceptance and capital. Operations are conducted primarily in mainland China through a Cayman holding-company structure.
Company facts
No analyst consensus on record.
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, Dec 31, 2025Cash & short-term investments $8.0M · Total debt $0 · Total assets $15.9M · Shareholders' equity $15.3M
- Revenue
- $81.4M
- Operating income
- −$1.0M
- Net income
- $1.1M
Reported in CNY, converted at the latest exchange rate
No dividends on record.
| Institutions | 0.06% | 465 ADS | |
|---|---|---|---|
| 3 holders · as of Mar 31, 2026 | |||
| Other | 99.94% | 774.9K ADS | |
| remainder | |||
775.3K ADS as of Aug 21, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing
Some positions are filed in underlying shares, not receipts; the ratio is unknown, so no percentage.
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Date |
|---|---|---|---|
Rhumbline AdvisersInstitution | 0.04% | 3,021 ADS | as of Mar 31, 2026 |
UBS Group AGInstitution | 0.02% | 1,534 ADS | as of Mar 31, 2026 |
JPMorgan Chase & CoInstitution | 0.00% | 95 ADS | as of Mar 31, 2026 |
Insider tradesForm 4
Nothing filed in the last 12 months.
- Compass Minerals
Sleep and EEG diagnostics overlap in institutional brain monitoring.
- Ceribell
AI-enabled portable EEG overlaps in rapid brain-signal interpretation.
CompareAfter hours
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| VisionSys AI (ADR) | $1.98 | +1.54% | $1.6M | — | — | — | — |
| Compass Minerals | $23.80 | −0.02% | $989.0M | 54.8 | 19.4 | 0.8 | +0.3% |
| Ceribell | $24.25 | +0.04% | $920.1M | — | — | 9.0 | +32.5% |
| Median | 54.8 | 19.4 | 4.9 | +16.4% |